Cargando…
Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292414/ http://dx.doi.org/10.1186/2051-1426-2-S3-P200 |
| _version_ | 1782352480768622592 |
|---|---|
| author | Reuben, Alexandre Cooper, Zachary A Amaria, Rodabe N Forget, Marie A Haymaker, Cara Bernatchez, Chantale Chen, Pei-ling Tetzlaff, Michael T Chin, Lynda Dwyer, Karen C Wargo, Jennifer A |
| author_facet | Reuben, Alexandre Cooper, Zachary A Amaria, Rodabe N Forget, Marie A Haymaker, Cara Bernatchez, Chantale Chen, Pei-ling Tetzlaff, Michael T Chin, Lynda Dwyer, Karen C Wargo, Jennifer A |
| author_sort | Reuben, Alexandre |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4292414 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42924142015-01-15 Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma Reuben, Alexandre Cooper, Zachary A Amaria, Rodabe N Forget, Marie A Haymaker, Cara Bernatchez, Chantale Chen, Pei-ling Tetzlaff, Michael T Chin, Lynda Dwyer, Karen C Wargo, Jennifer A J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4292414/ http://dx.doi.org/10.1186/2051-1426-2-S3-P200 Text en Copyright © 2014 Reuben et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Reuben, Alexandre Cooper, Zachary A Amaria, Rodabe N Forget, Marie A Haymaker, Cara Bernatchez, Chantale Chen, Pei-ling Tetzlaff, Michael T Chin, Lynda Dwyer, Karen C Wargo, Jennifer A Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma |
| title | Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma |
| title_full | Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma |
| title_fullStr | Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma |
| title_full_unstemmed | Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma |
| title_short | Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma |
| title_sort | intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292414/ http://dx.doi.org/10.1186/2051-1426-2-S3-P200 |
| work_keys_str_mv | AT reubenalexandre intrapatientintratumoralimmuneheterogeneityisevidentatprogressionontargetedtherapyandimmunotherapyformelanoma AT cooperzacharya intrapatientintratumoralimmuneheterogeneityisevidentatprogressionontargetedtherapyandimmunotherapyformelanoma AT amariarodaben intrapatientintratumoralimmuneheterogeneityisevidentatprogressionontargetedtherapyandimmunotherapyformelanoma AT forgetmariea intrapatientintratumoralimmuneheterogeneityisevidentatprogressionontargetedtherapyandimmunotherapyformelanoma AT haymakercara intrapatientintratumoralimmuneheterogeneityisevidentatprogressionontargetedtherapyandimmunotherapyformelanoma AT bernatchezchantale intrapatientintratumoralimmuneheterogeneityisevidentatprogressionontargetedtherapyandimmunotherapyformelanoma AT chenpeiling intrapatientintratumoralimmuneheterogeneityisevidentatprogressionontargetedtherapyandimmunotherapyformelanoma AT tetzlaffmichaelt intrapatientintratumoralimmuneheterogeneityisevidentatprogressionontargetedtherapyandimmunotherapyformelanoma AT chinlynda intrapatientintratumoralimmuneheterogeneityisevidentatprogressionontargetedtherapyandimmunotherapyformelanoma AT dwyerkarenc intrapatientintratumoralimmuneheterogeneityisevidentatprogressionontargetedtherapyandimmunotherapyformelanoma AT wargojennifera intrapatientintratumoralimmuneheterogeneityisevidentatprogressionontargetedtherapyandimmunotherapyformelanoma |